Skip to main content
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ATNM ISIN · US00507W2061 LEI · 549300LCY1NZSXCQDT45 US Manufacturing
Open in API
Filings indexed 493 across all filing types
Latest filing 2014-09-25 Director's Dealing
Country US United States of America
Listing US ATNM

About Actinium Pharmaceuticals, Inc.

https://www.actiniumpharma.com/

Actinium Pharmaceuticals, Inc. is a clinical-stage company focused on developing targeted radiotherapies for patients with cancers lacking effective treatment options. The company's platform utilizes potent radioisotopes, such as the alpha-emitter Actinium-225, conjugated to monoclonal antibodies to precisely deliver radiation to cancer cells. Its clinical pipeline addresses hematologic malignancies and solid tumors. Key programs include Iomab-B, a targeted conditioning agent for bone marrow transplant in patients with relapsed or refractory Acute Myeloid Leukemia (AML), and Actimab-A, a CD33-targeting therapy for AML. The company is also advancing ATNM-400, a novel non-PSMA therapeutic for prostate cancer, and developing its proprietary Actinium-225 manufacturing technology and infrastructure.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2014-09-25 English
QUARTERLY REPORT
Interim / Quarterly Report Q2 2014
2014-08-12 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text mentions a press release providing a mid-year update to shareholders, attached as an exhibit. The document does not contain detailed financial statements or comprehensive financial analysis, but rather an announcement of an event (mid-year update). The length is 2417 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-08-04 English
REGISTRATION STATEMENT
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans or equity incentive plans. The text includes detailed information about the stock plans, the number of shares to be registered, and the purpose of the registration. It is not an annual report, earnings release, or any other financial report. It is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-07-07 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details an offering of 1,670,000 shares of common stock, including pricing, underwriting discounts, use of proceeds, risk factors, and business overview. The document is focused on a capital raising event and the terms of the stock offering, not on financial results, management changes, or other report types. It is a detailed disclosure related to financing activities and capital structure changes. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement of a report but a full prospectus supplement describing the offering terms and business context.
2014-06-25 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 25, 2014. It announces the entry into a material definitive agreement related to an underwriting agreement for a public offering of common stock. The content focuses on financing activities, including details about the offering price, number of shares, underwriting discounts, and expected proceeds. There are no financial statements or detailed financial performance data included, only an announcement of a financing event. This fits the definition of a Capital/Financing Update (CAP). The document length is 5337 characters, which is sufficient to contain substantive information about the financing event rather than just a brief announcement. Therefore, the appropriate classification is CAP with high confidence.
2014-06-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.